Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
about
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.Is ITP a thrombophilic disorder?Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Long-term complications of splenectomy in adult immune thrombocytopenia.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
P2860
Q30250259-2CFA730F-C395-4A9D-B34F-103B7FD37C30Q30399669-6E294838-F99A-4B71-8284-5C91D5BDEDDCQ33406643-690CA7D1-1E4E-419C-81EC-203959FE568FQ33410348-487AB0C0-241C-4A50-B932-5E64364C3E23Q33415996-2772EAE1-0A10-4EBB-A6C1-12080D7B164FQ33418453-2F6B614B-60CE-4351-A27E-9964925BC7F0Q33424664-52C044DD-9CFE-44BF-A94A-4AD24EF4FE49Q33425644-A1178D54-24C5-4F0D-A117-D61F34B849D0Q33427394-4C19BAF2-605C-4595-833B-7119015F5E92Q33431551-555E24F1-4A26-4C83-B951-CCB6F5212EBBQ33437227-E4C6B91D-587A-4106-89A9-A3D8B6F92C68Q33439412-6B23D344-2E99-40C4-A346-40C4700F71C0
P2860
Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Risk of arterial thrombosis in ...... population-based cohort study.
@en
Risk of arterial thrombosis in ...... population-based cohort study.
@nl
type
label
Risk of arterial thrombosis in ...... population-based cohort study.
@en
Risk of arterial thrombosis in ...... population-based cohort study.
@nl
prefLabel
Risk of arterial thrombosis in ...... population-based cohort study.
@en
Risk of arterial thrombosis in ...... population-based cohort study.
@nl
P2093
P2860
P50
P1476
Risk of arterial thrombosis in ...... population-based cohort study.
@en
P2093
Annette Østergaard Jensen
Merete Lund Maegbaek
Steven Cha
P2860
P304
P356
10.1111/J.1365-2141.2012.09231.X
P407
P577
2012-07-23T00:00:00Z